Revenue and Organic Growth
Revenue of EUR 2.223 billion in FY2025 with organic growth of 1.5%, supported by volume, mix (0.5%) and pricing (1%).
EBITDA Above Guidance
EBITDA of EUR 306.9 million (13.8% margin), which was above the October guidance and demonstrates resilience in a challenging environment.
Strong Free Cash Flow and Cash Conversion
Free cash flow of EUR 120 million, representing a cash conversion of almost 40% of EBITDA; working capital improvements (trade NWC reduced to 0.2% of revenue from 0.7% in 2024) were major contributors.
Value Creation Metrics
Return on invested capital (ROIC) of 12.1%, well above the group's WACC of ~8%, and earnings per share increased by 5.7% to EUR 4.25.
Balance Sheet and Financing Progress
Leverage reduced to 2.6x; announced repayment of remaining hybrid principal CHF 144.3 million at end-April 2026; total financing costs improved to EUR 41.6 million (over EUR 4 million better than low end guidance), with hybrid buyback contributing ~EUR 23 million of savings.
Innovation and Portfolio Strength
Innovation accounted for 19% of revenue and was accretive to growth, supporting margin resilience and product mix.
Regional Outperformance and Operational Progress
Rest of World delivered 2.9% organic growth and an EBITDA margin improvement of 110 basis points to 20.9%; Europe delivered 1.3% organic growth with broad-based contribution from Ireland, France, Germany and Poland.
Cost Savings and Transformation Roadmap
Midterm program targets net savings of EUR 20–30 million (gross EUR 40–60 million from operations/procurement/structure) with ~EUR 20–30 million to be reinvested in digital/AI; identified ~EUR 10 million gross annual structural cost reduction from organizational alignment.